Assessing SPP1/Osteopontin (OPN) Splice Variants and Their Association to Nonmelanoma Skin Cancer by Absolute Quantification: Identification of OPN-5 Subvariants and Their Protein Coding Potential

References

• Platzer G, Schedlbauer A, Chemelli A, Ozdowy P, Coudevylle N, Auer R, et al. The metastasis-associated extracellular matrix protein osteopontin forms transient structure in ligand interaction sites. Biochemistry. 2011;50(27):6113–6124. doi:10.1021/bi200291e.
   PubMed Web of Science ®Google Scholar
• Kurzbach D, Platzer G, Schwarz TC, Henen MA, Konrat R, Hinderberger D. Cooperative unfolding of compact conformations of the intrinsically disordered protein osteopontin. Biochemistry. 2013;52(31):5167–5175. doi:10.1021/bi400502c..
   PubMed Web of Science ®Google Scholar
• Denhardt DT, Burger EH, Kazanecki C, Krishna S, Semeins CM, Klein-Nulend J. Osteopontin-deficient bone cells are defective in their ability to produce NO in response to pulsatile fluid flow. Biochem Biophys Res Commun. 2001;288(2):448–453. doi:10.1006/bbrc.2001.5780..
   PubMed Web of Science ®Google Scholar
• Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol. 2007;27(11):2302–2309. doi:10.1161/ATVBAHA.107.144824..
   PubMed Web of Science ®Google Scholar
• McKee MD, Pedraza CE, Kaartinen MT. Osteopontin and wound healing in bone. Cells, Tissues, Organs. 2011;194(2–4):313–319. doi:10.1159/000324244.
   PubMed Web of Science ®Google Scholar
• Rittling SR, Novick KE. Osteopontin expression in mammary gland development and tumorigenesis. Cell Growth Differ. 1997;8(10):1061–1069.
   PubMedGoogle Scholar
• Furger KA, Menon RK, Tuckl AB, Bramwelll VH, Chambers AF. The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med. 2001;1(5):621–632. doi:10.2174/1566524013363339.
   PubMedGoogle Scholar
• Hsieh YH, Juliana MM, Hicks PH, Feng G, Elmets C, Liaw L, et al. Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin. Cancer Res. 2006;66(14):7119–7127. doi:10.1158/0008-5472.CAN-06-1002..
   PubMed Web of Science ®Google Scholar
• Chang PL, Hsieh YH, Wang CC, Juliana MM, Tsuruta Y, Timares L, et al. Osteopontin facilitates ultraviolet B-induced squamous cell carcinoma development. J Dermatol Sci. 2014;75(2):121–132. doi:10.1016/j.jdermsci.2014.05.002.
   PubMed Web of Science ®Google Scholar
• Lee SH, Park JW, Woo SH, Go DM, Kwon HJ, Jang JJ, et al. Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice. Oncotarget. 2016;7(52):87219–87231. doi:10.18632/oncotarget.13529..
   PubMedGoogle Scholar
• Lee SH, Park JW, Go DM, Kim HK, Kwon HJ, Han SU, et al. Ablation of osteopontin suppresses N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric cancer development in mice. Carcinogenesis. 2015;36(12):1550–1560. doi:10.1093/carcin/bgv144.
   PubMed Web of Science ®Google Scholar
• Giopanou I, Kanellakis NI, Giannou AD, Lilis I, Marazioti A, Spella M, et al. Osteopontin drives KRAS-mutant lung adenocarcinoma. Carcinogenesis. 2020;41(8):1134–1144. doi:10.1093/carcin/bgz190..
   PubMed Web of Science ®Google Scholar
• Saitoh Y, Kuratsu J, Takeshima H, Yamamoto S, Ushio Y. Expression of osteopontin in human glioma. Its correlation with the malignancy. Lab Invest. 1995;72(1):55–63.
   PubMed Web of Science ®Google Scholar
• Lin J, Myers AL, Wang Z, Nancarrow DJ, Ferrer-Torres D, Handlogten A, et al. Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma. Oncotarget. 2015;6(26):22239–22257. doi:10.18632/oncotarget.4161..
   PubMedGoogle Scholar
• Kijewska M, Kocyk M, Kloss M, Stepniak K, Korwek Z, Polakowska R, et al. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma. Oncotarget. 2017;8(10):16340–16355. doi:10.18632/oncotarget.14092..
   PubMedGoogle Scholar
• Silva GR, Mattos DS, Bastos ACF, Viana B, Brum MCM, Ferreira LB, et al. Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines. Mol Biol Rep. 2020;47(10):8339–8345. doi:10.1007/s11033-020-05867-9..
   PubMed Web of Science ®Google Scholar
• Briones-Orta MA, Avendano-Vazquez SE, Aparicio-Bautista DI, Coombes JD, Weber GF, Syn WK. Osteopontin splice variants and polymorphisms in cancer progression and prognosis. Biochim Biophys Acta Rev Cancer. 2017;1868(1):93–108. doi:10.1016/j.bbcan.2017.02.005..
   PubMed Web of Science ®Google Scholar
• Gimba ERP, Brum MCM, Nestal De Moraes G. Full-length osteopontin and its splice variants as modulators of chemoresistance and radioresistance (review). Int J Oncol. 2019;54(2):420–430. doi:10.3892/ijo.2018.4656.
   PubMed Web of Science ®Google Scholar
• Buback F, Renkl AC, Schulz G, Weiss JM. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp Dermatol. 2009;18(9):750–759. doi:10.1111/j.1600-0625.2009.00926.x.
   PubMed Web of Science ®Google Scholar
• Chang PL, Harkins L, Hsieh YH, Hicks P, Sappayatosok K, Yodsanga S, et al. Osteopontin expression in normal skin and non-melanoma skin tumors. J Histochem Cytochem. 2008;56(1):57–66. doi:10.1369/jhc.7A7325.2007..
   PubMed Web of Science ®Google Scholar
• Hsieh YH, van der Heyde H, Oh ES, Guan JL, Chang PL. Osteopontin mediates tumorigenic transformation of a preneoplastic murine cell line by suppressing anoikis: an Arg-Gly-Asp-dependent-focal adhesion kinase-caspase-8 axis. Mol Carcinog. 2015;54(5):379–392. doi:10.1002/mc.22108..
   PubMed Web of Science ®Google Scholar
• Hameetman L, Commandeur S, Bavinck JN, Wisgerhof HC, de Gruijl FR, Willemze R, et al. Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients. BMC Cancer. 2013;13:58. doi:10.1186/1471-2407-13-58..
   PubMed Web of Science ®Google Scholar
• Garcia-Diez I, Hernandez-Munoz I, Hernandez-Ruiz E, Nonell L, Puigdecanet E, Bodalo-Torruella M, et al. Transcriptome and cytogenetic profiling analysis of matched in situ/invasive cutaneous squamous cell carcinomas from immunocompetent patients. Genes Chromosomes Cancer. 2019;58(3):164–174. doi:10.1002/gcc.22712..
   PubMed Web of Science ®Google Scholar
• Lambert SR, Mladkova N, Gulati A, Hamoudi R, Purdie K, Cerio R, et al. Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling. Br J Cancer. 2014;110(2):520–529. doi:10.1038/bjc.2013.760..
   PubMed Web of Science ®Google Scholar
• Lin WJ, Duffy A, Chen CY. Localization of AU-rich element-containing mRNA in cytoplasmic granules containing exosome subunits. J Biol Chem. 2007;282(27):19958–19968. doi:10.1074/jbc.M702281200..
   PubMed Web of Science ®Google Scholar
• Dhamija S, Menon MB. Non-coding transcript variants of protein-coding genes - what are they good for? RNA Biol. 2018;15(8):1025–1031. doi:10.1080/15476286.2018.1511675..
   PubMed Web of Science ®Google Scholar
• Gao YA, Agnihotri R, Vary CP, Liaw L. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments. Matrix Biol. 2004;23(7):457–466. doi:10.1016/j.matbio.2004.09.003.
   PubMed Web of Science ®Google Scholar
• Christensen B, Schack L, Klaning E, Sorensen ES. Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D. J Biol Chem. 2010;285(11):7929–7937. doi:10.1074/jbc.M109.075010..
   PubMed Web of Science ®Google Scholar
• Hoac B, Susan-Resiga D, Essalmani R, Marcinkiweicz E, Seidah NG, McKee MD. Osteopontin as a novel substrate for the proprotein convertase 5/6 (PCSK5) in bone. Bone. 2018;107:45–55. doi:10.1016/j.bone.2017.11.002..
   PubMed Web of Science ®Google Scholar
• Pearton DJ, Nirunsuksiri W, Rehemtulla A, Lewis SP, Presland RB, Dale BA. Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates. Exp Dermatol. 2001;10(3):193–203. doi:10.1034/j.1600-0625.2001.010003193.x..
   PubMed Web of Science ®Google Scholar
• Poswar FO, Fraga CA, Farias LC, Feltenberger JD, Cruz VP, Santos SH, et al. Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma. Pathol Res Pract. 2013;209(11):705–709. doi:10.1016/j.prp.2013.08.002.
   PubMed Web of Science ®Google Scholar